Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00047411 · ClinicalTrials.gov registry record · Phase 3
Home Use of Automatic External Defibrillators to Treat Sudden Cardiac Arrest
A Phase 3 study of Cardiovascular Diseases and Heart Diseases, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- Phase 3
- Development phase
- 7,001
- Enrollment target
- 1
- Study location
NCT00047411 is a Phase 3 study of Cardiovascular Diseases and Heart Diseases that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 7,001 participants, below the 26,951-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00047411, a Phase 3 study of Cardiovascular Diseases and Heart Diseases, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 7,001 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare home use of an automatic external defibrillator (AED) to the use of local emergency medical system in treating survivors of sudden cardiac arrest.
Conditions Studied
Interventions
- OTHER Cardiopulmonary Resuscitation
- DEVICE Automatic External Defibrillation
Study Locations (1)
Washington
- Seattle Institute for Cardiac Research - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,001 participants |
| Start Date | 2002-09 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00047411
The ClinicalTrials.gov registry entry for NCT00047411 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 7,001 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,951-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (74% lower). The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Cardiopulmonary Resuscitation is the first listed.
NCT00047411 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00047411 about?
NCT00047411 is a clinical study titled "Home Use of Automatic External Defibrillators to Treat Sudden Cardiac Arrest". To compare home use of an automatic external defibrillator (AED) to the use of local emergency medical system in treating survivors of sudden cardiac arrest.
What is the current status of trial NCT00047411?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 7,001 participants. The study started on 2002-09. Estimated completion is 2007-09.
What conditions does trial NCT00047411 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Diseases, Myocardial Infarction, Death, Sudden, Cardiac.
What interventions are being tested in trial NCT00047411?
The interventions under investigation include: Cardiopulmonary Resuscitation (OTHER), Automatic External Defibrillation (DEVICE).
Who is sponsoring clinical trial NCT00047411?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00047411 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
RECRUITING · Phase 3
-
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RECRUITING · Phase 3
-
Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs
RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
ACTIVE NOT RECRUITING · Phase 3
-
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
ACTIVE NOT RECRUITING · Phase 3
-
Comparison of Hematocrit Levels in Infant Heart Surgery
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.